Guardant Health Director Alex M. Azar II Acquires Shares via RSU Vesting
Guardant Health, Inc.
Subscribe to track GH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📊 Form 4 Filing Alert: Guardant Health, Inc. ($GH) Insider: Alex M. Azar II (Director) Action: Acquisition (RSU Settlement) Shares Transacted: 137 Price: $0.00 Value: $0.00 Post-Transaction Direct Ownership: 962 shares Significance: Low (Routine scheduled vesting)
Comprehensive Analysis
Executive Summary
On October 12, 2026, Guardant Health, Inc. ($GH) director Alex M. Azar II acquired 137 shares of common stock through the scheduled vesting and settlement of restricted stock units (RSUs). Following this transaction, Azar directly holds 962 common shares and 4,816 unvested RSUs.
Transaction Details
- Date of Transaction: October 12, 2026
- Security: Common Stock
- Transaction Code: M (Exercise or conversion of derivative security exempted under Rule 16b-3)
- Shares Acquired: 137 shares at $0.00 per share
- Derivative Security Converted: 137 Restricted Stock Units
- Vesting Schedule: Award granted September 12, 2025; 25% vested September 12, 2026, with the remainder vesting monthly over 36 months.
Market and Trading Context
This acquisition represents the non-discretionary settlement of a previously disclosed equity grant and involves no open-market purchases or sales. Because there was no market-driven capital commitment or insider liquidation, the transaction holds low informational value for broader market sentiment.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.